NICE recommends oral migraine treatment for first time
An oral small molecule CGRP antagonist has been recommended for episodic migraines in National Institute for Health and Care Excellence (NICE) final draft guidance.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
